PRFX
PRFX
NASDAQ · Pharmaceuticals

Prf Technologies Ltd

$2.30
+0.10 (+4.55%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +420.0% upside
Low Target $8.59
Average Target $11.96
High Target $16.97
Current Price $2.30
Current
$2.30
Target
$11.96
$8.59 $11.96 avg $16.97
Scenario Analysis
Bear Case
$8.59
273.5%
Low target
Base Case
$11.96
+420.0%
Avg target
Bull Case
$16.97
+637.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$17.95
-87.2% from high
52-Week Low
$2.27
+1.3% from low
Target vs 52W High
$11.96
-33.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%